Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Autolus Therapeutics (AUTL) Inventory (2024 - 2025)

Autolus Therapeutics (AUTL) has disclosed Inventory for 2 consecutive years, with $27.7 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Inventory changed N/A year-over-year to $27.7 million, compared with a TTM value of $27.7 million through Sep 2025, changed N/A, and an annual FY2024 reading of $4.1 million, changed N/A over the prior year.
  • Inventory was $27.7 million for Q3 2025 at Autolus Therapeutics, up from $23.9 million in the prior quarter.
  • Across five years, Inventory topped out at $27.7 million in Q3 2025 and bottomed at $4.1 million in Q4 2024.